LDL Reduction from Ezetimibe
Ezetimibe, when used alone (monotherapy), reduces LDL-C by roughly 15-25%, with studies showing an average reduction of about 18-20%. The primary effectiveness of ezetimibe is in combination with statins, where it can provide an additional 21-30% reduction in LDL-C, leading to greater overall cholesterol reduction.
Ezetimibe Mechanism
- Ezetimibe works by inhibiting cholesterol absorption in the small intestine.
- Other Effects: It can also lead to a modest increase in HDL-C and a decrease in triglycerides.
Ezetimibe Monotherapy
- Efficacy: As a standalone therapy, it can lower LDL-C by approximately 18-20%.
- Ezetimibe alone can reduce apoB levels by roughly 17-20%.
Ezetimibe with Statins
- Synergistic Effect: The greatest benefits of ezetimibe are seen when it's added to statin therapy.
- When combined with a statin, ezetimibe can produce an additional 21% to 30% reduction in LDL-C.
(Source: Google AI Overviews, which I spot checked)

